Increasing Prevalence And Incidence Of Organ Failure Is Fostering The Growth Of The Medical Bionic Implants Market
Bionic implants are one of the leading technologies for those who suffer from mobility disabilities. They are generally used by amputees and other individuals with limited mobility but are becoming increasingly popular among patients suffering from a range of different conditions. The most common use for medical bionic implants is to replace prosthetic limbs. Patients suffering from strokes, traumatic injuries, or those with endometriosis can often benefit from this technology as these device helps to restore function and ease the pain.
The high burden of chronic disease coupled with the advancement in medical implants
is fueling the growth of the medical bionic implants market. Moreover, the
increasing number of accidents is another key factor augmenting the growth of
the medical bionic implants market. According to the Association for Safe
International Road Travel, around 1.35 million people die in road crashes each
year; on average 3,700 people lose their lives every day on the roads. An
additional 20-50 million suffer non-fatal injuries, often resulting in
long-term disabilities. Additionally, growing age-related disorders such as
cataracts, hearing loss, arthritis, and cardiovascular diseases are also
propelling the growth of the market. Furthermore, the increasing prevalence of
organ failure in patients is further anticipated to foster the growth of the
medical bionic implants market.
From
the regional assessment, North America is projected to gain significant growth
over the forecast period and this is attributed to the increasing launch of
innovative medical implants in the region. For instance, in December 2020,
Advanced Bionics (AB), a developer of cochlear implant technology, in
partnership with Phonak, a provider of life-changing hearing solutions,
received FDA approval and announced the launch of Marvel hearing technology to
Advanced Bionics cochlear implant wearers.
Key Developments:
1. In November 2020, Konami has
partnered with the prosthetic limb designer Open Bionic, to launch a 3D printed
bionic arm inspired by the Metal Gear Solid (MGS) video game character Venom
Snake.
2. In January 2021, Advanced Bionics
Introduces New Cochlear Implant Sound Processors on Marvel Platform
3. In November 2019, Jumbo Group
announced a partnership with Modern Bionic Limb Solutions (MOBILIS) Medical
Manufacturing for 3D printing of prosthetic covers, orthosis, hand and leg
splints, sockets, and other devices in the UAE and GCC region.
4. In February 2020, UCL has
partnered on a £5.2million grant from Wellcome Trust which will establish the
new Manufacture of Active Implant and Surgical Instruments (MAISI) facility,
located in St Thomas’ Hospital.
Comments
Post a Comment